BNC2 and breast carcinoma: To test our hypothesis that BNC2 drives a mesenchymal phenotype, BNC2 was knocked down in three breast cancer cell lines (BT549, HS578T, and mesHMLE) in which it is relatively highly expressed (Fig 2A–C) or was induced in MCF7 cells in which it is not normally present (Fig 2D and E).